ReproCELL Incorporated (JASDAQ:4978) acquired the remaining 0.87% stake in BioServe Biotechnologies (India) Pvt Ltd. for INR 0.85 million on July 10, 2019. ReproCELL acquired 0.02 million shares. BioServe Biotechnologies became a wholly owned subsidiary of ReproCELL. BioServe Biotechnologies had revenues of INR 46.9 million, net loss of INR 33.4 million, total assets of INR 150.1 million and net assets of INR 131.8 million in the year ending March 2019. ReproCELL Incorporated (JASDAQ:4978) completed the acquisition of the remaining 0.87% stake in BioServe Biotechnologies (India) Pvt Ltd. on July 10, 2019.